SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (CHO) (20µg) (Special Terms Apply*)
We're always working hard to give our customers as much information on products and the best price possible. If you need any assistance or would like a quote please contact us and we will be happy to help
SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (CHO) (20µg) (Special Terms Apply*) (QTXAG-635-20) is recombinant SARS-CoV-2 Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) is expressed in CHO cells using a C-terminal His-tag to greater than 95% purity. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Recombinant SARS-CoV-2 Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) is expressed in CHO cells using a C-terminal His-tag to greater than 95% purity. These proteins can be used as diagnostic standard antigens, targets of neutralizing antibodies and in the development of antibodies to detect SARS-CoV-2 in patients. They are manufactured using a mammalian expression system as this is more immunogenic than proteins produced in E. coli. *Special Terms: Please see product specification details below and our Ordering page for details.
Q-TOX Term 2: Minimum Order Volume of 1000µg on Orders Requiring Dry Ice Shipment
